The device allows the preparation of an ophthalmic gel based on Carboxymethylcellulose (CMC) and Ematik PRP for the treatment of corneal ulcers and symptoms related to dry eye syndrome. The ophthalmic solution has the same pH and osmolarity as physiological tears.

The density of the CMC increases ocular absorption of PRP.
The device provides a 6-day treatment that supports corneal epithelial regeneration, offers an anti-inflammatory effect, and helps maintain ocular hydration and lubrication.